Von dem Buch Progress in Drug Research Progress in Drug Research haben wir 2 gleiche oder sehr ähnliche Ausgaben identifiziert!

Falls Sie nur an einem bestimmten Exempar interessiert sind, können Sie aus der folgenden Liste jenes wählen, an dem Sie interessiert sind:

Progress in Drug Research Progress in Drug Research100%: Mitarbeiter: Q.May Wang, Mitarbeiter: Beverly A. Heinz, Mitarbeiter: Jay A. Glasel, Mitarbeiter: Gerlie C.de los Reyes, Mitarbeiter: Robert T. Koda, Mitarbeiter: Eric J. Lien, Mitarbeiter: Angelo Vedani, Mitarbeiter: Max Dobler, Mitarbeiter: Paul A. Keife: Progress in Drug Research Progress in Drug Research (ISBN: 9783034895446) in Englisch, Taschenbuch.
Nur diese Ausgabe anzeigen…
Progress in Drug Research50%: Angelo Vedani, Beverly A. Heinz, Eric J. Lien, Gerlie C.de los Reyes, Jay A. Glasel, Laurane G. Mendelsohn, Max Dobler, Paul A. Keifer, Q.May Wang, Robert T. Koda, Satya P. Gupta: Progress in Drug Research (ISBN: 9783034883856) in Deutsch, auch als eBook.
Nur diese Ausgabe anzeigen…

Progress in Drug Research Progress in Drug Research
6 Angebote vergleichen

Preise2013201420152021
SchnittFr. 73.23 ( 74.65)¹ Fr. 83.39 ( 85.00)¹ Fr. 93.54 ( 95.36)¹ Fr. 83.92 ( 85.55)¹
Nachfrage
Bester Preis: Fr. 53.60 ( 54.64)¹ (vom 03.09.2013)
1
9783034895446 - Progress in Drug Research
Symbolbild

Progress in Drug Research (1989)

Lieferung erfolgt aus/von: Vereinigte Staaten von Amerika DE PB NW

ISBN: 9783034895446 bzw. 3034895445, in Deutsch, Birkhäuser, Taschenbuch, neu.

Fr. 99.88 ( 101.81)¹ + Versand: Fr. 3.53 ( 3.60)¹ = Fr. 103.41 ( 105.41)¹
unverbindlich
Von Händler/Antiquariat, BuySomeBooks [52360437], Las Vegas, NV, U.S.A.
Paperback. 336 pages. Dimensions: 10.0in. x 7.0in. x 0.8in.Hepatitis C virus (HCV) was first identified in 1989 as the etiologic agent of non-A, non-B hepatitis 1 and is currently recognized as the leading cause of chronic liver disease worldwide. In contrast to hepatitis B virus infection, in which only about 5 of adult infections become chronic, more than 80 of HCV-infected patients develop chronic hepatitis. Moreover, 20-50 of those persistently infected with HCV will develop liver cirrhosis and hepatocellu lar carcinoma (HCC) 2. It is estimated that there are 10, 000 deaths in the USA per year due to chronic liver failure or HCC 3. In addition, HCV dis 25-50 of all liver transplants in US centers, and the ease is responsible for recurrence of HCV infection following liver transplantation is universal 4. Typically, HCV disease emerges after a 10-20 year period during which symp toms, if they exist at all, are mild and non-specific. Although the prevalence varies greatly among different countries, it has been estimated that up to 170 million people (3 of the worlds population), are infected with HCV 5. A recent study in the USA found that 65 of all HCV-infected persons are 30 to 49 years old 6. This item ships from multiple locations. Your book may arrive from Roseburg,OR, La Vergne,TN.
2
9783034895446 - Mitarbeit: Jucker, Ernst, Mitarbeit: Wang, Q.May Heinz, Beverly A. Glasel, Jay A. Reyes, Gerlie C.de los Koda, Robert T.: Progress in Drug Research
Mitarbeit: Jucker, Ernst, Mitarbeit: Wang, Q.May Heinz, Beverly A. Glasel, Jay A. Reyes, Gerlie C.de los Koda, Robert T.

Progress in Drug Research

Lieferung erfolgt aus/von: Deutschland DE PB NW

ISBN: 9783034895446 bzw. 3034895445, in Deutsch, Birkhäuser, Taschenbuch, neu.

Fr. 70.58 ( 71.95)¹
versandkostenfrei, unverbindlich
Lieferung aus: Deutschland, Versandkostenfrei.
buecher.de GmbH & Co. KG, [1].
Hepatitis C virus (HCV) was first identified in 1989 as the etiologic agent of non-A, non-B hepatitis [1] and is currently recognized as the leading cause of chronic liver disease worldwide. In contrast to hepatitis B virus infection, in which only about 5% of adult infections become chronic, more than 80% of HCV-infected patients develop chronic hepatitis. Moreover, 20-50% of those persistently infected with HCV will develop liver cirrhosis and hepatocellu lar carcinoma (HCC) [2]. It is estimated that there are 10,000 deaths in the USA per year due to chronic liver failure or HCC [3]. In addition, HCV dis 25-50% of all liver transplants in US centers, and the ease is responsible for recurrence of HCV infection following liver transplantation is universal [4]. Typically, HCV disease emerges after a 10-20 year period during which symp toms, if they exist at all, are mild and non-specific. Although the prevalence varies greatly among different countries, it has been estimated that up to 170 million people (3% of the world's population), are infected with HCV [5]. A recent study in the USA found that 65% of all HCV-infected persons are 30 to 49 years old [6].Softcover reprint of the original 1st ed. 2000. 2012. viii, 336 S. 31 SW-Abb., 3 Farbabb., VIII, 336 p.Versandfertig in 3-5 Tagen, Softcover.
3
9783034895446 - Q.May Wang; Beverly A. Heinz; Jay A. Glasel; Gerlie C.de los Reyes; Robert T. Koda; Eric J. Lien; Angelo Vedani; Max Dobler; Paul A. Keifer; Laurane G. Mendelsohn; Satya P. Gupta: Progress in Drug Research
Q.May Wang; Beverly A. Heinz; Jay A. Glasel; Gerlie C.de los Reyes; Robert T. Koda; Eric J. Lien; Angelo Vedani; Max Dobler; Paul A. Keifer; Laurane G. Mendelsohn; Satya P. Gupta

Progress in Drug Research (1989)

Lieferung erfolgt aus/von: Deutschland ~EN PB NW

ISBN: 9783034895446 bzw. 3034895445, vermutlich in Englisch, Springer Shop, Taschenbuch, neu.

Fr. 83.92 ( 85.55)¹
versandkostenfrei, unverbindlich
Lieferung aus: Deutschland, Lagernd.
Hepatitis C virus (HCV) was first identified in 1989 as the etiologic agent of non-A, non-B hepatitis [1] and is currently recognized as the leading cause of chronic liver disease worldwide. In contrast to hepatitis B virus infection, in which only about 5% of adult infections become chronic, more than 80% of HCV-infected patients develop chronic hepatitis. Moreover, 20-50% of those persistently infected with HCV will develop liver cirrhosis and hepatocellu­ lar carcinoma (HCC) [2]. It is estimated that there are 10,000 deaths in the USA per year due to chronic liver failure or HCC [3]. In addition, HCV dis­ 25-50% of all liver transplants in US centers, and the ease is responsible for recurrence of HCV infection following liver transplantation is universal [4]. Typically, HCV disease emerges after a 10-20 year period during which symp­ toms, if they exist at all, are mild and non-specific. Although the prevalence varies greatly among different countries, it has been estimated that up to 170 million people (3% of the world's population), are infected with HCV [5]. A recent study in the USA found that 65% of all HCV-infected persons are 30 to 49 years old [6]. Soft cover.
4
9783034895446 - PROGRESS IN DRUG RESEARCH -:
Symbolbild
PROGRESS IN DRUG RESEARCH -

9783034895446 (2012)

Lieferung erfolgt aus/von: Deutschland DE PB NW

ISBN: 9783034895446 bzw. 3034895445, in Deutsch, Birkhäuser, Taschenbuch, neu.

Fr. 99.54 ( 101.47)¹ + Versand: Fr. 10.74 ( 10.95)¹ = Fr. 110.28 ( 112.42)¹
unverbindlich
Von Händler/Antiquariat, Herb Tandree Philosophy Books [17426], Stroud, GLOS, United Kingdom.
9783034895446 Paperback, This listing is a new book, a title currently in-print which we order directly and immediately from the publisher.
5
9783034895446 - Progress in Drug Research

Progress in Drug Research

Lieferung erfolgt aus/von: Vereinigte Staaten von Amerika DE NW

ISBN: 9783034895446 bzw. 3034895445, in Deutsch, Birkhauser Basel, Birkhauser Basel, neu.

Fr. 74.28 ($ 95.38)¹
unverbindlich
Lieferung aus: Vereinigte Staaten von Amerika, zzgl. Versandkosten, Free Shipping on eligible orders over $25.
Contribution by Q.May Wang, Contribution by Max Dobler, Contribution by Jay A. Glasel, Contribution by Eric J. Lien, Contribution by Laurane G. Mendelsohn, Contribution by Beverly A. Heinz, Contribution by Satya P. Gupta, Contribution by Angelo Vedani, C.
6
9783034895446 - Progress in Drug Research
Symbolbild

Progress in Drug Research (2012)

Lieferung erfolgt aus/von: Deutschland DE PB NW RP

ISBN: 9783034895446 bzw. 3034895445, in Deutsch, Birkhäuser, Taschenbuch, neu, Nachdruck.

Fr. 89.92 ( 91.66)¹ + Versand: Fr. 3.42 ( 3.49)¹ = Fr. 93.34 ( 95.15)¹
unverbindlich
Von Händler/Antiquariat, English-Book-Service - A Fine Choice [1048135], Waldshut-Tiengen, Germany.
This item is printed on demand for shipment within 3 working days.
Lade…